Search Results - GenHong Di
- Showing 1 - 9 results of 9
-
1
Association between socioeconomic factors at diagnosis and survival in breast cancer: A population‐based study by Peng Ji, Yue Gong, Chang‐Chuan Jiang, Xin Hu, Gen‐Hong Di, Zhi‐Ming Shao
Published in Cancer Medicine (2020-03-01)Get full text
Article -
2
-
3
-
4
Integrated analysis reveals prognostic value of HLA-I LOH in triple-negative breast cancer by Yi Xiao, Xi Jin, Yi-Zhou Jiang, Zhi-Ming Shao, Yi-Fan Zhou, Gen-Hong Di
Published in Journal for ImmunoTherapy of Cancer (2021-10-01)Get full text
Article -
5
Rational and trial design of FASCINATE-N: a prospective, randomized, precision-based umbrella trial by Wen-Jia Zuo, Li Chen, Yu Shen, Zhong-Hua Wang, Guang-Yu Liu, Ke-Da Yu, Gen-Hong Di, Jiong Wu, Jun-Jie Li, Zhi-Ming Shao
Published in Therapeutic Advances in Medical Oncology (2024-02-01)Get full text
Article -
6
A prospective, phase II, neoadjuvant study based on chemotherapy sensitivity in HR+/HER2‐ breast cancer‐FINEST study by Li Chen, Wen‐Ya Wu, Fei Liang, Guang‐Yu Liu, Ke‐Da Yu, Jiong Wu, Gen‐Hong Di, Lei Fan, Zhong‐Hua Wang, Jun‐Jie Li, Zhi‐Ming Shao
Published in Cancer Communications (2025-04-01)Get full text
Article -
7
ER-poor and HER2-positive: a potential subtype of breast cancer to avoid axillary dissection in node positive patients after neoadjuvant chemo-trastuzumab therapy. by Jian-Wei Li, Miao Mo, Ke-da Yu, Can-Ming Chen, Zhen Hu, Yi-Feng Hou, Gen-Hong Di, Jiong Wu, Zhen-Zhou Shen, Zhi-Ming Shao, Guang-Yu Liu
Published in PLoS ONE (2014-01-01)Get full text
Article -
8
Comprehensive genomic profiling of breast cancers characterizes germline-somatic mutation interactions mediating therapeutic vulnerabilities by Chao Chen, Cai-Jin Lin, Yu-Chen Pei, Ding Ma, Li Liao, Si-Yuan Li, Lei Fan, Gen-Hong Di, Song-Yang Wu, Xi-Yu Liu, Yun-Jin Wang, Qi Hong, Guo-Liang Zhang, Lin-Lin Xu, Bei-Bei Li, Wei Huang, Jin-Xiu Shi, Yi-Zhou Jiang, Xin Hu, Zhi-Ming Shao
Published in Cell Discovery (2023-12-01)Get full text
Article -
9
Neoadjuvant anthracycline followed by toripalimab combined with nab-paclitaxel in patients with early triple-negative breast cancer (NeoTENNIS): a single-arm, phase II studyResearc... by Min He, Shuang Hao, LinXiaoxi Ma, BingQiu Xiu, BenLong Yang, ZeHao Wang, JingYan Xue, YaYun Chi, Min Xiong, JiaJian Chen, XiaoYan Huang, XiYu Liu, SongYang Wu, Qin Xiao, Yan Huang, RuoHong Shui, AYong Cao, JunJie Li, GenHong Di, WenTao Yang, Xin Hu, GuangYu Liu, KeDa Yu, YiZhou Jiang, ZhongHua Wang, ZhiMing Shao, Jiong Wu
Published in EClinicalMedicine (2024-08-01)Get full text
Article
